Padcev

Padcev Description

Manufacturer:

Baxter Oncology GmbH

Distributor:

Zuellig Pharma

Marketer:

Astellas Pharma
Full Prescribing Info
Description
Each vial contains either 20 mg or 30 mg enfortumab vedotin active ingredient that is reconstituted to a final concentration of 10 mg/mL.
Enfortumab vedotin is an antibody-drug conjugate (ADC) comprised of a Nectin-4 directed, fully human Chinese Hamster Ovary (CHO)-expressed IgG1-kappa monoclonal antibody conjugated to the microtubule-disrupting agent monomethyl auristatin E (MMAE) via a protease-cleavable maleimidocaproyl valine-citrulline (vc) linker.
Excipients/Inactive Ingredients: Histidine, Histidine hydrochloride monohydrate, Trehalose dihydrate, Polysorbate 20.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in